Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
about
Restoring immune tolerance in neuromyelitis optica: Part IMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeRelationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disordersAzathioprine does not reduce adenoma formation in a mouse model of sporadic intestinal tumorigenesis.Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersNeuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis.Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.Therapeutic options in neuromyelitis optica spectrum disorders.Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.Effects of early using azathioprine in the acute phase in neuromyelitis optica spectrum disorder.Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients.Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial.Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders.Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.Diagnosis and Treatment of NMO Spectrum Disorder and MOG-EncephalomyelitisLow-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China
P2860
Q28072382-A26409CC-8408-4D7D-8BF7-1CC18F1240E1Q30371412-066F369E-5960-4647-8565-F0D2FD49D356Q33876453-9AC7A846-B569-4724-BA85-2175F25F48CDQ34589786-3D0480C6-D216-4D86-A5FD-4752A5B382AAQ36118869-2A734836-D7E0-4C42-B2FE-75A2CA8D1276Q36484394-E358F5CC-6930-400A-A554-1B810C5D1438Q36695909-B720476E-3576-4839-BE5A-F4879FAA03D2Q36696590-42894937-2BB9-48B8-A22C-0BDAD597E443Q36727762-B8A63767-DB3F-4F70-9A77-3D8DD7987A7CQ38721559-257B835A-2209-4FA6-B09A-37D8EA1DD196Q38750021-F9752333-CF0F-41D5-A773-C2CECCB2A91AQ38870861-E5B32DC9-5A81-4A53-9755-21D29EF27926Q41096503-04E8F1BD-12BA-4CB8-9847-572FFB1244D4Q48198452-2800B2B0-0467-4BF7-91A4-C53D042F7C22Q53125112-1E701340-1D45-4EDD-98E7-38A5062915FBQ53214289-EE6223F2-B59A-4E1B-B6E6-DBB10A89F7DDQ58573155-C7EA0510-5DE6-4DB3-8153-836BCE621E3CQ58750166-D408E71D-4964-4F41-BFDA-C49418E9E517
P2860
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Long-term efficacy, tolerabili ...... servational study from the UK.
@en
type
label
Long-term efficacy, tolerabili ...... servational study from the UK.
@en
prefLabel
Long-term efficacy, tolerabili ...... servational study from the UK.
@en
P2093
P2860
P356
P1476
Long-term efficacy, tolerabili ...... servational study from the UK.
@en
P2093
Benjamin McNeillis
Daniel Lythgoe
Jackie Palace
Joanna Kitley
Kathryn Moss
Kerry Mutch
Liene Elsone
M Isabel Leite
Neil Robertson
P2860
P304
P356
10.1177/1352458514525870
P577
2014-03-19T00:00:00Z